Prediction of thyroidal 131I effective half-life in patients with Graves' disease | Zendy

Ruiguo Zhang | Zendy; Guizhi Zhang | Zendy; Renfei Wang | Zendy; Jian Tan | Zendy; Yajing He | Zendy; Zhaowei Meng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prediction of thyroidal 131I effective half-life in patients with Graves' disease

Author(s) -

Ruiguo Zhang,

Guizhi Zhang,

Renfei Wang,

Jian Tan,

Yajing He,

Zhaowei Meng

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.20849

Subject(s) - trab , medicine , graves' disease , anti thyroid autoantibodies , discontinuation , endocrinology , thyroid , hormone , wolff–chaikoff effect , thyroid peroxidase , univariate analysis , thyroid function , gastroenterology , multivariate analysis , antibody , autoantibody , immunology

Calculation of effective thyroidal half-life (Teff) of iodine-131( 131 I) is cumbersome and tedious. The aim of this study was to investigate factors that could be used to predict Teff and to develop a Teff prediction model in Graves' disease patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research